Showing posts with label genome sequencing. Show all posts
Showing posts with label genome sequencing. Show all posts

Monday, January 28, 2008

Sequencing 1000 Human Genomes - How Many Do We Really Need?

A group of the world's leading sequencing centers have announced plans to sequence 1000 human genomes. The cost of the first human genome project was about $3 billion; by comparison, the next 1000 will be a steal at possibly only $50 million dollars (and that's total cost, not per genome). But that's still a lot of money - why are we investing so much in sequencing genomes? It may be a lot up front, but the benefits, in terms of both economics and medical research, easily outweigh the cost of such a large project. By pooling sequencing resources and making large amounts of genome sequence data available up front, we can avoid inefficient and redundant sequencing efforts by groups of independent research groups trying discover gene variants involved in disease. In fact, it would probably be worthwhile to sequence 10,000 human genomes. With 1000 genomes, we're at least making a good start.

The 1000 genomes project comes at a time when new, genome-wide disease studies have created a need for an extensive catalog of human genetic variation, and new technology has provided a potentially efficient way to fill that need. Genome-wide association studies have scanned the genomes of thousands of people, sick and healthy, to find regions of DNA that may be involved in diseases like diabetes and heart disease. These studies have highlighted regions of our chromosomes that could be involved in disease, but the genome scans used are often still too low-resolution for researchers to pinpoint that exact genetic variant that might be involved. In many cases there dozens or more genes inside of a disease-linked region, any of which could be the disease gene of interest. As a result, groups that do these genome-wide studies have to invest considerable time and resources mapping genetic variants at higher resolution - which of course significantly increases the effort required to get anything useful out of genome-wide association studies. What we need is a much better, much more detailed catalog of all the spots where humans vary in their genomes.

Although we're all roughly 99.9% similar in our genomes, that still leaves millions of DNA positions where we vary. And often we don't just vary at single DNA base-pairs (instances where in one position you might have a 'T', while I have a 'C'); small deletions and insertions of stretches of DNA also exist, and can be involved in disease. The 1000 genomes project intends to map both single-base changes and these 'structural variants.'

Many genetic variants important in health show up in just 1%, 0.1%, or even 0.01% of the population. Imagine a medically important genetic variant present in just 0.1% of the U.S. population; 300,000 people will have this variant and will be possibly at risk for a particular disease. Knowing about such variants could help us understand how the disease develops, and possibly design prevention and treatment strategies. For 300,000 people in the U.S, and millions more around the world, it would therefore be a good thing to know about this variant. But to find those rare variants, we can't just sequence 100 human genomes, and even with 1000, we would miss a lot.

So it's obvious that 1000 genomes is just a start. To go more aggressively after rare variants that are likely to be medically important, the 1000 genomes group is going to also focus in on the small gene-containing fraction of the human genome. This will enable them to put more resources into finding rare variants near genes - places where we expect medically important variants to show up.

And let's not forget the technological benefits: by using next-generation sequencing technology, which is still not quite mature, this consortium hopes to develop innovative ways to effectively and cheaply re-sequence human genomes. In both physical technology and data analysis methods, we'll see benefits that will lead to more widespread use of this technology, hopefully in clinical diagnostics as well as research.

It has been nearly 20 years since the Human Genome Project officially began. We're still waiting for the promised medical benefits to emerge, but in the mean time, this effort has transformed biological research - in my opinion, at least as much as the foundational discoveries of molecular biology in the 50's and 60's. Future medical benefits will be based on this science.

Thursday, January 10, 2008

What Next Generation DNA Sequencing Means For You

Of all the 'Greatest Scientific Breakthroughs' of 2007 heralded in the pages of various newspapers and magazines this past month, perhaps the most unsung one is the entrance of next-generation DNA sequencing onto the stage of serious research. Prior to this year, the latest sequencing technologies were limited in their usefulness and accessibility due to their cost and a steep technical learning curve. That's now changing, and a group of recent research papers gives us a hint of just how powerful this new technology is going to be. Not only will next-generation sequencing be the biggest change in genomics since the advent of microarray technology, but it may also prove to be the first genome-scale technology to become part of every-day medical practice.

Sanger DNA sequencing is one of the most important scientific technologies created in the 20th century. It's the dominant method of sequencing DNA today, and very little of the best biological research of the last 20 years could have been done without it, including the whole genome sequencing projects that have thoroughly transformed modern biology. Now, new next-generation sequencing methods promise to rival Sanger sequencing in significance.

So what's so great about the latest sequencing technology? Sanger sequencing is inherently a one-at-a-time technology - it generates a single sequence read of one region of DNA at a time. This works well in many applications. If you're sequencing one gene from one sample, Sanger sequencing is reliable, and generates long sequence reads that, under the right conditions, can average well over 500 nucleotide bases. You get a nice clean readout of a single strand of DNA, as you can see in this example:



Modern sequencing machines that use this method generate a 4-color fluorescent dye readout, which you can see in the graph in the figure. Each peak of fluorescence in the graph represents one nucleotide base, and you know which base it is from the color of the dye.

Next-generation sequencing, also called pyrosequencing, can't generate the nice, long sequence reads you get with Sanger sequencing, nor are the individual reads as accurate. Instead of 500 DNA bases or more, you just get about 25 bases. But the difference is that you get lots and lots of sequence reads. Instead of just one long read from just one gene (or region of the genome), you get thousands of short, error-prone reads, from hundreds or thousands of different genes or genomic regions. Why exactly is this better? The individual reads may be short and error prone, but as they add up, you get accurate coverage of your DNA sample; thus you can get accurate sequence of many regions of the genome at once.

Next-generation sequencing isn't quite ready to replace Sanger sequencing of entire genomes, but in the meantime, it is poised to replace yet another major technology in genomics: microarrays. Like next-generation sequencing, microarrays can be used to examine thousands of genes in one experiment, and they are one of the bedrock technologies of genomic research. Microarrays are based on hybridization - you're basically seeing which fluorescently labeled DNA from your sample sticks (hybridizes) to spots of DNA probes on a microchip. The more fluorescent the spot, the more DNA of that particular type was in the original sample, like in this figure:



But quantifying the fluorescence of thousands of spots on a chip can be unreliable from experiment to experiment, and some DNA can hybridize to more than one spot, generating misleading results.

Next-generation sequencing gets around this by generating actual sequence reads. You want to know how much of a particular RNA molecule was in your sample? Simply tally up the number of sequence reads corresponding to that RNA molecule! Instead of measuring a fluorescent spot, trying to control for all sorts of experimental variation, you're just counting sequence reads. This technique works very well for some applications, and it has recently been used to look at regulatory markings in chromatin, to find where a neural regulatory protein binds in the genome, to look at the differences between stem cells and differentiated cells, and to see how a regulatory protein behaves after being activated by an external signal.

I've left out one the major selling points of this technology: it's going to be cheap. You get a lot of sequence at a fairly low cost. And this is why it may end up being the one technology that truly brings the benefit of genomics into our every-day medical care. Because next-generation sequencing is cheap and easy to automate, diagnostics based on sequencing, especially cancer diagnostics will become much more routine, and so will treatments based on such genetic profiling. It will be much easier to look at risk factors for genetic diseases. Microbial infections will be easier to characterize in detail.

All of this is still a few years off, but the promise of this technology is already apparent enough to include it among the great breakthroughs of 2007.

Go look at the very informative websites of 454 Life Sciences, Illumina, and Applied Biosystems, the major players in next-generation sequencing.

For more on Sanger sequencing, check out Sanger's Nobel Lecture (pdf file).

A recent commentary and primer on next-generation sequencing in Nature Methods (subscription required).

Friday, January 04, 2008

How To Grow a New Head: The Amazing Regenerative Powers of Planaria

Planarians have fascinated centuries of biologists by their amazing powers of regeneration. If you decapitate a planarian, the body can grow a new head, and the head can grow a new body. In fact, if you cut out a very tiny chunk from the side of a planarian, that chunk will be able to regenerate a new, complete organism. How do these strange critters manage this? What genes do they have that we don't have? As it turns out, most planarian genes are shared with humans, and several groups of scientists are using the latest tools of genomics and molecular biology to figure out just what it is that gives planarians their remarkable powers of regeneration. These researchers hope that planarians will ultimately teach us how to regenerate human injuries.




Planarians are small flatworms that live in ponds and rivers on almost every continent. They are among the most simple organisms that possess a central nervous system: behind the two cross-eyed looking eye spots is a small bundle of neurons that serves as a brain. Extending from the brain is a primitive yet effective nervous system. Planarians also have a digestive system, and, in some species, both male and female reproductive organs (sexual planarians are hermaphrodites). All of these specialized tissues can be regrown from a tiny chunk (as few as about 10,000 cells) cut out of the side of the worm. The great geneticist Thomas Morgan, before he went on to do his famous fruitfly work, discovered (in the kind of work that would be a 10 year-old boy's dream come true) that as little as 1/279th of a planarian is enough to regrow the entire body. This is an incredible feat for such a small chunk of cells - the cells have to reorient themselves, establishing anterior and posterior ends, as well as bilateral symmetry. These cells also have to reform every type of tissue in the organism. (For some fascinating pictures of a regrowing head, check out this PDF file.)

Revealing the Secrets of Regeneration

The secret to these remarkable powers are stem cells, called neoblasts, scattered throughout the organism. How these neoblasts function in regeneration has been the focus of intense research, notably in the labs of Alejandro Sanchez Alvarado at the University of Utah, and Phillip Newmark, at the University of Illinois, Urbana-Champaign. These researchers are using the latest tools of genetics, such as knocking down genes with RNAi, to identify those genes that enable these stem cells to properly rebuild complete planarian bodies. And to leverage all of the tools that modern molecular biology has to offer, the Genome Sequencing Center at Washington University is currently sequencing a planarian genome.

Researchers in Alvorado lab recently identified two important genes involved in this process, genes that just happen to be important genes in all animals, including humans. These researchers found that when they shut down a beta-catenin gene using RNAi, planarians with amputated tails would grow a new head, instead of a new tail. In fact, shutting down beta-catenin could also transform tails into heads in whole animals with no amputated parts at all. The Alvorado lab also found that a gene which antagonizes beta-catenin, called APC (the planarian version of a gene involved in human colon cancer), has the opposite effects of beta-catenin: shutting down APC results in planarians that regrow tails in the place of amputated heads. These two genes, highly conserved in all animals, thus appear to work as master switches in planarian regeneration. An important emerging theme in modern biology is that the amazingly diverse traits found among animals is not the result of new genes for each new feature; instead, this diversity arises from how a core set of genes is put to use. Planarians share the majority of their genes with us, which means that we may some day learn how planrians use their genetic toolkit, and thus be able to manipulate human genes to perform such amazing feats of regeneration. While we won't be regrowing human heads, there is a very real hope that we'll be able to regrow human nerve tissue, such as spinal cords.

Planrians in Evolution

Planarians are also remarkable examples of creatures that appear 'half-way evolved' (of course modern planarians have been evolving as much as we have): they have features that likely resemble evolutionary intermediates of complex vertebrate organs, such as eyes. Planarian eyes don't have lenses, but they do have light sensing cells hooked up to the central nervous system, as well as a curved 'optic cup' that enables planarians to gain some information about the direction of a light source. Another primitive feature of planarians are the early cell divisions of planarian embryos: in contrast with the highly ordered process seen in vertebrates, planarian embryos undergo a series of very disordered cell divisions. And yet this system of disordered embryogenesis produces perfectly good adult organisms. People often find it hard to imagine how evolution can produce complex processes or structures, such as human eyes, or the development of a human embryo. How could an eye progressively evolve? In planarians, we can see that much more primitive physiological systems, having only some of the features of their more complex human counterparts, can be perfectly functional and therefore sustained by natural selection.


For more on planarians, and some fun pictures, check out:

http://www.planarians.org/
and this cool picture.

Photo credit: Wikipedia commons (uploaded by Alejandro Sanchez), under the Creative Commons License

Tuesday, August 21, 2007

Domesticating Biotechnology in the 21st Century

Will we domesticate biotechnology in the next 50 years? More than 150 years of spectacular advances in physics, chemistry, and computing have thoroughly transformed the way we live. Yet so far, the big revolutions in molecular biology have had their impact primarily on professional laboratories, not our everyday lives. What do we need to do in order to domesticate biotech?

Physicist Freeman Dyson recently explored this question:

"Will the domestication of high technology, which we have seen marching from triumph to triumph with the advent of personal computers and GPS receivers and digital cameras, soon be extended from physical technology to biotechnology?"

Dyson predicts this will happen in the next 50 years:

"I predict that the domestication of biotechnology will dominate our lives during the next fifty years at least as much as the domestication of computers has dominated our lives during the previous fifty years."

What form might this domestication take? Among Dyson's suggestions for domestication is user-friendly genetic engineering for hobbyist plant and animal breeders. I'm not so sure that making genetic engineering idiot-proof is the major hurdle; in fact, genetic engineering today is somewhat of an oxymoron. We may be able to engineer pet fish to express a green fluorescent protein, but we honestly have no clue how to engineer any but the most simple, monogenic traits.

We will dometicate biotechnology, and I predict that this will happen in two ways: by bringing biotech into the day-to-day practice of medicine, and by bringing genetic engineering to a truly sophisticated level, on par with aerospace engineering.

Bringing Biotech into the Clinic
To be honest, with the exception of imaging technology, medicine as practiced today is extremely low-tech. Very few of the fancy techniques that scientists use in a molecular biology lab are available on a routine, affordable basis in the clinic. Blood tests are downright primitive. And in spite of all of our sophisticated genome analysis technology, detailed genotyping is almost never used in medicine. Biotech is ripe for domestication in the clinic.

Dirt Cheap Genome Sequencing
One day, every newborn child will be routinely genotyped; that is, the hospital lab will take a blood sample and, quickly and cheaply, determine that baby's DNA sequence in the millions of places where humans can differ. Our genotype will become part of our medical records, which of course we ourselves will also have access to. Genotyping can be used to customize drug and disease treatments, as well as suggest lifestyle choices that will help avoid or minimize diseases that a person may be susceptible to. Universal genotyping can even be used by family history hobbyists.

The technological barriers will soon be overcome, leaving the social ones remaining as the largest obstacle to universal genotyping. Who can have access to this information? How much do you really want to know about your disease susceptibility? Your paternity? These aren't trivial questions.

The Universal Blood Test
High-tech, preventative diagnostics will transform the way we practice medicine. Most of today's diagnostic tests, with the exception of medical imaging, are based on decades-old techniques. Leroy Hood, a founder of Seattle's Institute for Systems Biology is working on technology for affordable, routine blood tests that will provide a comprehensive picture of your health, including the very early detection of diseases like cancer. These blood tests, one day cheap enough to be done annually, could thoroughly modernize preventative medicine.

Real Genetic Engineering
At Boeing, engineers can essentially design a new plane completely by computer, and predict in minute detail how that plane will behave in real-world weather. True genetic engineering will mean being able to make such quantitative predictions with the cell, but currently our abilities to make quantitative predictions are embarrassingly small. Analogous to Boeing's computer-aided design, computer aided genetic engineering will one day enable us to develop gene replacement therapies that don't have cancer as a side effect, develop specific, side effect-free drugs that treat tough diseases, and develop microbes that can generate energy from renewable resources, clean up toxic spills, or perform chemical reactions that organic chemists haven't yet been able to achieve.

The first step towards achieving this level of sophistication will be to completely understand all of the parts of an organism; the next will be to understand how those parts work as a system. We've nearly reached that first step for a eukaryotic organism: brewer's yeast, one of biology's key model organisms, will have an essentially completely annotated parts list within the next 10 years or so. Many scientists are now struggling with the next step, trying to make sense of how these parts work as a system. Yeast will be the first Boeing 747 of biology - an organism that we can completely and predictively model by computer, without extensive trial and error studies in the lab.

Maybe, after we've really learned how to do genetic engineering, hobbyists will then fulfill Dyson's dream of user-friendly plant design, and come up with a way to make glow-in-the-dark roses.

Tuesday, August 14, 2007

Ancient Microbes Revived from Antarctic Ice May Be Spreading Their Genes

After being encased in Antarctic ice for 8 million years, ancient microbes thawed by a team of researchers revved up their metabolic engines again and began making proteins and replicating. These are the oldest organisms ever brought back to life after a deep freeze.

The research team, a group primarily from Rutgers, looked at the microbial population in some of the oldest ice known on earth, obtained from Antarctica’s Beacon Valley. Using microscopy, the researchers could see that these samples had a variety of bacteria encased inside. But microscopy can only tell you so much; to learn more, the research team turned to DNA sequencing.

The standard way of identifying what you have in a mixed population of bacteria is to sequence the 16S ribosomal DNA - a gene encoding an important component of the protein-synthesizing machinery. This gene is plays such an important functional role that it changes very slowly over evolutionary time, thus allowing scientists to easily compare DNA sequences among organisms that have diverged from each other for hundreds of millions of years. The 16S rDNA sequences from these ice samples revealed nearly a dozen different types of bacteria in the 8 million-year-old ice; that’s not much compared to a fresh, modern sample of seawater, but that's great for very old ice.

Some of these ancient bacteria were alive. When the researchers melted the ice (but keeping it still cold and dark - these are sensitive bacteria), they found that at least some of the bacteria were able start up their metabolism, which was measured using radioactive metabolites that the bacteria could ingest and incorporate into their protein or DNA.

16S rDNA can tell you what kinds of bacteria you have, but another intriguing question is what genes do these bacteria have? Are most of their genes similar to those of today’s known bacteria? After sequencing as much of the bacterial genomes as they could, the researchers found that a substantial 46% of the genome sequence did not match any known genes. This is not actually so surprising - in spite of all of the DNA sequence from thousands of organisms stored in GenBank, we know that we have sampled only a fraction of the different types of genomes on earth. The genomes of multicellular organisms are relatively similar to each other, but that bacterial world represents a vast, poorly explored genetic resource. We know most of the genes on our planet are in fact missing from our databases; we best understand the biology of that small subset of bacterial and archaebacterial genes that was present in the ancestors of all eukaryotic organisms.

While scientists may not know much about most bacterial genes, evolution is not blind to them. Bacteria are remarkably generous with their genes; they pass them on not only to their descendants, but to their neighbors as well. This phenomenon of lateral gene transfer, or LGT, makes the evolutionary analysis of bacteria fiendishly difficult. The authors of the ice microbes paper raise another fascinating (or depressing, if you study bacterial evolution) possibility: that ancient ice is a “gene popsicle,” facilitating gene transfer not only across species, but also across time. With the onset of an ice age, microbes, harboring a given set of genes, get preserved for thousands or millions of years, until the ice melts. That’s when these ancient bacteria return to the local ecosystem, where they can pass on their ancient genes via LGT to modern bacterial species. These modern species then, with luck, use these recently revived genes to better adapt to their environment. As the authors of the paper put it:

“Our analysis suggests that melting of polar ice in the geological past may have provided a conduit for large-scale... LGT, potentially scrambling microbial phylogenies and accelerating the tempo of microbial evolution.”

This is a mind-boggling prediction, which will be difficult to test without a lot more bacterial genome sequencing. However, the idea again demonstrates the tremendous resources evolution has to work with. As the biologist Leslie Orgel reportedly once said, “Evolution is cleverer than you are.”

Thursday, July 05, 2007

Junk DNA in the Opossum Genome

Vertebrate genomes are full of junk. Despite the occasional confusing magazine article, the spurious claims by creationists, or obfuscatory statements by some scientists, we know that our genomes are stuffed full of DNA sequence that serves no functional role for the organism. The vast bulk of this junk sequence consists of molecular parasites, called transposable elements, whose only 'function' is to replicate themselves. While our genomes obviously contain critical information required to build and maintain ourselves, they are also vast ecosystems of virus-like parasites that have colonized our DNA.

A recent paper in the journal Genome Research describes the DNA ecosystem of the opossum genome. "Ecosystem" is not an exaaggeration; more than 52% of the opossum genome is comprised of transposable elements, which can be classed into nearly 500 different families. Transposable elements are similar to viruses; they are, one way or another, able to replicate themselves within an organism's genome and get passed on to the next generation. These elements have variety of survival strategies; some elements get transcribed into RNA and then 'reverse transcribed' back into DNA and inserted somewhere in the genome, while other elements never go through an RNA stage. Some transposable elements encode proteins that enable them to spread through the genome more efficiently; other elements don't bother to code for any proteins and instead hijack the proteins produced by those elements that can code for them.

Why do transposable elements exist in our genomes? Because they can. If a DNA element in an organism's genome can get itself passed on into the next generation, whether that element is beneficial to the organism or not, then obviously it will remain in the genome of that species. Since these elements don't generally serve any functional role, there is no reason for natural selection to preserve them, and we thus see piles of defective copies of transposable elements scattered around our genomes. These elements no longer have the ability to spread through the genome and they serve no function - they are pure junk. While our cells do have systems that try to stop these elements from spreading, we, and most animals, have not evolved effective ways to get rid of the junk elements once they are there; these elements therefore hang around and bulk up our genomes with non-functional material. About 45% of the human genome consists of these elements; that fraction rises to 52% for the opossum (which has a genome slightly larger than ours).

Transposable elements are not completely useless. For one, biologists love them because they can be helpful for studying evolutionary history - one approach to teasing out relationships among various species is to reconstruct a rough history of transposable element activity in various genomes. We have also known for some time that these elements can occasionally be recruited for a functional role (such as telemoeres in flies, X-chromosome inactivation in mammals, and centromeres in various organisms).

The opossum paper offers even more tantalizing, although not wholly unprecedented, evidence of a larger role for transposable elements. The authors of this paper looked at transposable elements, common to both opossum and human, that were present in known or suspected regulatory regions of the genome. Transposable elements in these regions are obvious candidates for a functional role. And remarkably, the researchers found that a handful of transposable element families were highly abundant in these regulatory regions - in one case, 70% of all the individual elements of one family were found in regulatory regions of the genome. It is possible that this particular family of transposable elements somehow contains a useful 'regulatory module,' some sequence that has been recruited through evolution to control the expression some genes. If this is true, than this would be a case of transposable elements providing the raw genetic material to create new layers of regulation in the genome.

So while most of the self-perpetuating transposable element ecosystem is undoubtedly junk from the perspective of the organism hosting it, our genomes are occasionally able to scoop up some of the detritus and put it to good use.

Tuesday, April 24, 2007

The Rhesus Macaque Genome - Can it help us learn about ourselves?

Just recently Science published the paper describing the latest primate genome - the rhesus macaque genome. (Check out Science's macaque website for some good (and free) articles on the subject.) Sequencing a large genome like this one is resource intensive (unlike microbial genomes, which are now easily and routinely sequenced), so why did scientists sequence yet another primate genome? In addition to the human genome we already have the chimp genome, and we also have several non-primate mammalian genomes - the mouse, rat, cow, dog, and opossum genomes. Is this a good use of our money? Why put in so much effort just to study evolution?

Evolution is worth studying in and of itself, however evolution is so tightly connected with every field of biology that it's hard to avoid evolution when you're studying anything else. We sequence these genomes because we know we can use evolutionary principles to understand the nuts and bolts of the genome. This strategy has been used already with great success in major genetic model organisms, including flies, worms, and yeast.

Most of us, I would bet, are more interested in the human genome than any other, and ultimately we sequence these primate genomes to understand our own genome. The chimp genome is helpful, but we need a more distantly related species to really enable us to effectively use genome comparison to learn about all those parts in our DNA. The rhesus macaque is a great pick, because it has been used extensively in medical research, and it is an Old World monkey - one of our closest relatives outside of the great apes.

Genome sequencing simply gives us raw sequence, such as this region from human chromosome 11:
(Sequence is read from left to right, line by line, like regular text.)

GAGGAGGCGGCGGAGGAGGGGCCGCCCGCGGCCCCCGGCTCACTCCGGCACTCCG
GGCCGCTCGGCCCCCATGCCTGCCCGACCGCGCTGCCGGAGCCCCAGGTCCGGGG
GCGGAGGGGAGCGCTGCCGCGGGGGTGGGCGGGCGGGGCGCGGGGGCCATGTGCG
AGCGCGGCAGGGAGGCGGGCGGGGCGGGCTGCAGGCGGGGTCCGACTCTGGGGCC
AGTCCGGGCCACGGTTGGGACCCAGTCGAGGGTCGGACTGGTCAGGGTTCAGGCG
GGATCCGGCGTCCGAGTCCTGGTGGGCCGGCCTGGGGCAGGATCTGGCTCTGGCT
GCGGGTCCTGACTCGGGTCAGGGTTGGGCCTCCGATCCAGCCCGCTCCGGGGCAG
GGTTCAATCCCGCATTTGCCGAAGTCCCTGGGGCTGGCCGGGGTGGAAGACGGGG
AGGGCTCTATGTCTGGGAAGGGGCTCTGAAGACCACGTGGGGGCGCTCGAAGGGG
CCTGGGGCCACCCTCCTCTCTGGGTCAAAGGTCATCGCACCGGCAGGGGAGAACT
TCCTCCTCCTTGGCTCTCCCCACTTACTTCCTGATAACCTGGTAGAGGTCTCCCG
CGGGCGGGGAGGGGGAGGCGTAGCAACTTTAGGCAACTTCCCAAAGGTGTGCGCA
GGTTGGGGGCGGGACGCGGCGCCCCGGGAGGTGGCGGCCTCTGCGACAGCGGGAG
TATAAGAGTGGACCTGCAGGCTGGTCGCGAGGAGGTGGAGCGGCGCCCGCCGTGT
GCCTGGGACCGGCATGCTGGGGCAGGAGGGCAGCCGCGTGTCAGGTGTGAAAAGC
TCTGGAGGTGTTTTCATGAGTCCGTGCCTGTGCGTGTGGATGTGGGGAGACCTAG
TGAGAGTGTGTGTGATCATGAGCCTTGACTGAGTTCGTGGATGGGGTGTGCGCTC
CAGGAGAAGTGTGTGAGCACAAGTGTGAGCAGGAGTGAGCACGGGTTTGGGAAGG
CCGGTGCAAGTGTGAAAGCCCTCAGCAGAGAGCGAGCCTGCGTGGGCTTGTGGGG
CTCCTGAGCACCCCGGTGAGTGGAGTGTGTGAACTCGGTGTGAGCACGTCCACTG
GCCTTGGGTCTGCTCTCCAATGCAGAATACCCAGATGAGGGCAGGGTCTCAGAGG
TCCCCCCAACATCTGGAGAAAACTGGGAAGTATCCTGCTCCTGGCTAGGGATTCC
AGGTGGGGTTGAAGGTTGCCTGGGGGCTACGGTTACCCTGCTCCCTGGCCTGGGT
GGGAGTAGGGGCTTTCTAAGCCTCCCCCAGGTTCCCAAGGGGGAGACCTGCTGTC
AGTTACTGGCCCTGAAGACTCTGTTTCCATGGCAACAGCTAGGAGGGGGCAGTGT
TCCTGGGCAGTCCTTCCTTGGACTCTGCCCCCCTTCTTCCCCACTTGCTGGGCTT
GGAAGCCTGGCCCTAGGCCCGAGGTTGGGCAACCCGTGTGGCAGGGTGTCTCCCA
TCCCCCATACCAGTGCTTTCCTGCGAACCTATGGGTCTCTCCGTGCAGGTGACCA
GCGCCATGTCCAGCCAGGTGGTGGGCATTGAGCCTCTCTACATCAAGGCAGAGCC
GGCCAGCCCTGACAGTCCAAAGGGTTCCTCGGAGACAGAGACCGAGCCTCCTGTG
GCCCTGGCCCCTGGTCCAGCTCCCACTCGCTGCCTCCCAGGCCACAAGGAAGAGG
AGGATGGGGAGGGGGCTGGGCCTGGCGAGCAGGGCGGTGGGAAGCTGGTGCTCAG
CTCCCTGCCCAAGCGCCTCTGCCTGGTCTGTGGGGACGTGGCCTCCGGCTACCAC
TATGGTGTGGCATCCTGTGAGGCCTGCAAAGCCTTCTTCAAGAGGACCATCCAGG
GTGAGCCCCCAGCCCACTCCCCTGTCCTTTGCCCTGCACCCTCTGGGTACACTGC
TGGGTGCAATAGGCCCCCTGATGGCTGTGGCACCGCTTGAGGCTAACAATCTGGT
GTTTCCAGTCCCTCTACCTCCCAGAGACACTCTTTCCCTGAGAAGTATGGTAAAA
GCACCGGGTGTGCTGATGCATTGCAGTGGATGTGAGTGAGTTCAGGGTACCACCT
GGGTACTCTAGGCCCAGCACCTTCTACAGTGGCTCTGAAAGAGTCCAAGGCAGCC
TCTGTCTGTTCCTAAGCTTTGTTCTTGTTTCTGGCAGCTTCTGACCTCTCCCCAG
CATAGAACATGTCCCCTTTTTGTTAATTTTCCCAAAGCAGCACCAACACAAGGCA
GATTTTAATTTTTTTTTTTTTGAGACAGAGTCTCACTCTGTTGTTCAGGCTAGAG
TGCAGTGGCACAATCTCTGCTCACTGCAACCTTTGCCCCTGGGTTCAAGAGATTC
TCCTGCCTCAGCCTCCTGAGTAGCTGAGACTGCAGGTGTGCACCACCACGCCCAG
CTAATTTTTGTATTTTTAGTAGAGACGACGTTTCACCATGTCGGCCAGGCTGGTC
TGGAATTCCTGACCACAAATGATCCACCTGCCTCGGCCTCCCAAAACAAGGCAGA
TTTTTATCAGTACTTGAGAGGGGCTACATCATAGTTTAGCACCCAACTTTAAAAA
GACTAACAGGCAAGGCCGGACACAGTTGCTCACACCTGTAATCCCAGCACTTTGG
GAGGCCAAGGTGGGCGGATCACCTGAGGTCAGGAGATCGAGACCAGCCTGGCCAG
GGTGGTGAAACCGCATCTCTACTAAAAATGCAAAAAATTAGCTGGGCATGGTGGC
TCGCGCCTGTAATCTCAGCTACTTGCTACTTGAGAGGCTGAGGCAGGAGAATTGC
TTGAACCCAGGAGGCAGAGGTTGCAGTGAGCCAAGATCACACCACTGTACTCCAG
CCTGGGTGACAGAGCGAGATTCCATCTCAAAAAAAAAAAAAAAAGGCCGGGCACT
GTGGCTCATGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGCGGATCATGAGGTC
AGGAGATTGAGAACATCCTGGCTAACACGGTGAAACACTGTCTCTACTAAAAATA
CAAAAAATTAGCTGGGCATGGTGGCGGGCGCCTGTAATCCCAGCTACTTGGGAGG
CTGAGGCAGGAGAATGGCGTGAACCCAGGAGGCGGAGGTTGCAGTGAGCCAAGAT
CACGCCACTGCACTCCAGCCTGGGCGACAGAGTGAGACTCCGTCTCAAAAAAAAA
AAAAAAAAGGCTGGGCGCGGTGGCTCATGCCTGTAATCCCAGCACTTTGGGAGGC
CGAGACGGGCGGATCACCTGAGGTCAGGAGTTTGAGACCAGCCTGACCAATGTGA
TGAAACCCCGTCTCTACTGAAAATACAAAAATTAGCCAAGCATGGTGGCATGCGC
CTGTCATCCCACTCAAGAGGCTGAGACAGGAGAATTGCTTGAACCTGGGAGGCAG
AGGTTGCAATGAGCCCAGATCGCGCCATTGCACTCTAGCCTGCGCAACAAAAGTG
AAACTCCACCTCAAAAAACAAAAACAAAAACAAAAACAAAAAAACCCAAAAACGC
TGGGCTTGGTGGCTCATGGCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCAGAC
GGATCACGAGGTCAGGAGTTCGAGACCAGCCTGGCCAACATGGTAAAACCCCGTC
TCTACTAAAAATACAAAAATTAGCCGGGCGTGGTGGTGAGTGCCTGTAATCCCAC
TACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCGGGAGGCAGAGGTTGCAG
TGAGCTGAGATCATGCCACAGCACTCTAGTCTGGGCAACAGAATGAGACACTCTC
ATCTCAAAAAAAAAAAAAAAAGGACTTACAGGCATGTCTGCTCTTAAAAGTCACT
AATTTTTTTCTCACTCAGGAAAGCTTATCAGAATTTGGGGGAATGAGCAAGATGC
TGACATTAAGCATTGCCTGGGAAGGGCCTATTATTTCCGTTATTTCTGCTTTTAT
GTAACCATTGGTTACTTTGGGGGCTATAACACGTATAATTAAAAAAAAAAAAAAA
AAGGCCAAGTGTGGTGGCTCACACCTGTAATCTCAGCACTTTCGGAGGCTAAGAT
GGGAGGATCACAAGGTCAGGAGTTCGAGACCAGCCTGGCCAACATGGTGAAACCC
TGTCTGTACTAGAAATACAAAAATTAGCCAGGTGTCGTGGTGGGTGCCTGTAGTC
CCAGCTACTCAGGAGGCTGAGGCAGGAGAATTGCTGGAACCCAGGAGGCAGAGGT
TGGAGTTAGCCAAGATCGTGCCACTGCACTCCCAGCCTGGGTGACAGAGTGAGAG
TTCGTATCAAAAAAAAAAAAAAAAAAAAAATCTTGAGTGCTTACCTTGTGCTAGG
CACTGTATTCTTTTATGATCTCAGTTAGTCCCCACAGCAACCCTATAAGGTGTCA
GTACTGTTATAACTGAAACTAAGAGAGGCATTTGAAACTTTGTTGAAGTCTCACA
ACTAGGAAATGGCAGAACCAAGATTTGAACTTGGGTCAGTATAGGTCCAGAGCTG
AGCTCTTCAATGTTAGACTGCTTCCTCTGCTTATTACTAATAACACCGAACTTTG
GACAGACGCTGAATGACTGATTGTGACATTCCAGCACGTTTTTTTTTTTTTTTTT
GAGACAGTCTCGTGTGGTCGCCCAGGCTGGAGTGCAGTGGCACGATCTCGGCTCA
CTGCAAGCTCCGCCTCCCGGGTTCACACCATTCTCCTGCCTCAGCCTCCTGAGTA
GCTGGGACTACAGGTGCCCGCCACCACGCCTGGCTAATTTTTTGTACTTTTAGTA
GAGACGGGGTTTCAGCGTGTTAGCCAAGATGGTCTTGATTTCCTGACCTCGAGAT
CCACCTGCCTTGGACTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACTGCTCCT
GGCCAGGTTTTTTTTTTTTTTTTTTTTTTTTTTGAGATGGAGTTTTGCTCTTGTT
GTCCAGGCTGGAGTGCAACGGCCTGCAGTCGTGGTTCACTGCAACCTCTGCCTCC
CGGGTTCAAGCCATTCACCTGCCTCAGCCTCCCAAGTAGCTGGGATTACAGGCGC
CTGCCACCATGCCCGGCTAATTTTTGTGTTTTTAGTAGGGATGGGGTTTCACCAT
GTTGGCCAGGCTGGCCTCAAACTCCTGACCTCAGGCGATCTGCCCTCCTCGGGCT
TCCAAAGTGCTGGGATTATAGGTGTGAGCCACTGCACCCCGCCAATCCAGCAAGT
TTTAACTTGGCCAAAATCCACCAATCTTAAACTTTGTGCACCCTTCCCACTCTGA
AGAACAGTGAGCCAGCCGGCCAGGGTGCGGGTATCTCCTACCTACCCTGGGGCCC
CTCACTGTATGTTGACTATTGACAAATATTTATTGTGTGCTGGCTGTGAATAGGA
CTTGTATATTGAGCACTTAGGTGTCATGAACCATGCTGGATGTTTTGACCATATT
ATCCCCTTTAATTCTCACGACCCAACTCTGTGGGGCACTTTTACAGCTGGGAAAC
TGAGGGTTCAAGGGGTTAGGTATGGGACTTGCCCAAGGTCATAAAGGTATGTGGT
AGCCAGAGTCCCTGTTCGGCACAGACCTGTTCTTTGCTGTCCTGGCCAGTGTTCC
AGGCCTTGGGGACATAGCTGGGGCTGAAGCAGGGCTGTTTCTGCCCTCAGGCAGT
TTACATCCTGGCAGAGGGGAGAGCTGGGCAACAGTGAGTTGCACAGACTTGTCTT
ATTACCGCTGTGGTATGTGCAGGAAGGGGAGGTGCTGGTTCTGAGGCTCCAGAGG
GCTTGTCTTTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTTTGTTGCCCAGGCTA
GAGTCCAGTGGCGCGATCTCGGCTCAGTGCAAGCTCCGCCTCCCGGGTTCAAGCG
ATTCTCCTGCCTCAGCCTCCCCAATAGCTGGGATTACAGGCGCATGGCACCACGC
ACGGCTAATTTTGGTATTTTTAGTAGAGACTGGGTTTCACCATGTTAGCCAGGAT
GGTCTCGATCTCCTGACCTCGTGATCCACCCGCCTCGGCCTCCCAAAGTGCTGGG
ATTACGCTCCCGGCCTCTTTTTTTTTTTAGACAGAGTCTCACTCTGTTGCCAGGC
TATAGTACAGTGGCACGATCTCAGCTTACTGCAACCTCCGCCTCCCAGGTTCAAG
CGATTGTTCTCCCTCAGCCTCCCGAGTAGCTGGGACTACAGGCACACGCCCAGCT
AATTTTTGTATTTTTAGTAGAGACAGGGTTTCACCGTGTTGGTCAGGCTGGTCTC
AAACTCCTCACCTCGTGATCTGCCTGCCTCGGCCTCCCAAAGTGCTGGGATTATA
GGCGTGAGCCACTGCGCCTGGCCTTTTTTTTTTTTTGGTACAGAGTTTCGCTCTG
GTTGCCCAGGCTGGAGTGCAATGGCACGATCTTGGCTCACTGCAGCCTCTGCCTC
CCGGGTTCAAGCGATTCTCCTGCCTCAGCCTCCGGAGCAGCTGGGATTACAGACA
TGCACCACCATGTCCGGCTAATTTTTTTTTTTCGAGATGGAGTCTCACTGTGTCA
CCCAGGCTGGAGTGCAGTGGCACAATCTCGGCTCACTGCAACCTCTGCCTCCCGG
GTTCAAGCGATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGACTACAGGTGCCTG
CCACCACACCCAGCTAATTTTTGTACTTTTAGTAGAGACGGGGTTTTACCATGTT
GGCCAGGCTGGTCTTGAACTTCTGACCTCAGGTGATCCACCCACCTCGGTCTCCC
AAAGTGCTGGGATTACAGGCGTGAGCCACCGTGCCCGGCCGTGGTGTCTTGAGCT
GAGTGCAGAAGCGCAAATAGGGGGTAGGAGAAAATGCACCGCGAGGAGAAATGTG
CTGCGGGCCTGCTGTCTAGCTGTGTCATTTGGTCGTTGCGGGGCCCTGTGAGGCC
GGGAGGGCTGCCAGCACCCACCATGTGCCAGGCCTCGTTGCTAGTGCTGGGGCCA
GTTCCTGCCCCGGTGGAGCTGCCACTGAAGGGGGAGGCGTAATAAACAAGATAGG
TGAGTGCATATGCAGCGTGGTCTGTTGTGCTGAGGGCTGAAGAGAAACCAGAAGC
AGGGCTCAGAGGCCAGGAGGACTCTGCAAAGGGATTTGGCATTATCACAGGGTGG
CCAGGGAAGATCTTCAAGGTGACAGTGAGCAGAGGGAGGTGAGGGAGCCTGTGTG
GACTTCAGGACTAGAGCTCCAGGCAGGGCCTGTTTGAGGAACATGGAGGAGGCGA
GAGCAAGGAGTAGAGGTCAAAAGGAGGCAAGAAGCAGGGGCGTAGGCCTAGGAGG
ACATAGGTTCGCTTTGGCTTGGACTCAGAGAAGGGAAATCCCCAGAGGGTTTTGA
GAAGAGGAGGTACAGGATGTAATGGAGGCTTAATAGGACCCTCTTGGCTGCTGAG
TCGAGAACAGACTGGAGCAAGCAGGGACAGCCAAGCGAGGGGCGAGGTGACAGTG
ACTATCAGGTCAAGGGTGGAAGTAGTTGCCAGGGGCAGGAGGCGGATTCTGGACC
TTGGAGGAGGTAAAGCCCACCAGAATGTGTCGGTGGCTTGGATGTGGGGTGTGAG
AGGAACCAGAGATTCTGCCTAGGTTTCTTCTTGGGCAAGTGAACACGTGGAGTCC
ACGTAGGCTGTGTTCGGTCCGAGATGCCTTCTAGACATGCAGGATGTCAAGGAGG
CAGCTGGAGAGATGGGTCTGGAGCTCACAGCAAGTCCAGGCTAGAGGTAGAAACG
TGAGAGCCCCACGGCTGGGGAAGATTGCCATGGGATTGGAGATGAGCTCCAAGGA
CAGCCCTGGCAGTCTGGATGGAAGAGCTTGGGAAGATGCTCAGAAACCACAAAGT
GGCTGGTGCGGTGGGAGGAAAACCAGAGTGTATGCTGTCCTAGAAGCAAAAGAAG
AAAGTGTTTCAGTGTTTCTAGGAGCAGGAAGTGATCAACAGCCTTAGATCCTCCT
TTTAGGCCAAGTAACATGAGGACTAAGAATTGACCACTGGATTTAGCAATGCAGA
GGTCCTTGTGGCCCTTGATGTCGGCAGATGAGGGCAGTGTGGTCCAGAGATGAGG
CTTGGGGCTGAGATGCAGCCCCGCTGCCTGGTCCAGCTCCTCCCTCATCCAGGCA
GGGCTCCCCCGCCCAGCAGCCACTCCCCTCCCTGCCTGCTCATGGCCCCCTGCTC
TCCCTTTCCTCCCCATACCCCCAGACCTGTGCTTGCCCGGGGAGAGTCAGGGCTC
TCCTGTCAGCTGGGTCCCCTCCCAGCCCCGGGAGGCCGCCACTGGAGCCCTGCCT
CTTCCTGGCAGGGAGCATCGAGTACAGCTGTCCGGCCTCCAACGAGTGTGAGATC
ACCAAGCGGAGACGCAAGGCCTGCCAGGCCTGCCGCTTCACCAAGTGCCTGCGGG
TGGGCATGCTCAAGGAGGGTGAGCGCTGGGCAGGGGCTGGGCGAGGGCTGGGGGA
GTCGGGGACCCGGGCCAGGTGGGGGTGAGGCCTGGGAGTTCTGGTGAGTGGACTC
GGG

I purposely included a long chunk (actually it's really a very tiny piece of chromosome 11) just to convey what this vast sea of unannotated sequence looks like. About all you could do with this is use the genetic code to see if there is something that looks like a protein-coding segment in there. But actual protein coding regions are very sparse, and broken into fragments called exons, which are spliced together before the final protein is made.

What we really want to know is where the gene is (in this case, an estrogen receptor gene) and it's controlling elements are. You won't be able to see the details below, but here is the big picture:




And here we're looking for only a few elements - I haven't included promoter regions, enhancers, non-coding RNAs, transposable elements... To find these elements requires three things:

- computer tools to build models of these elements and search the sequence
- sequence from related species for comparison
- experiments to test your computer predictions.

We have these three elements for yeast flies and worms, but in the case of humans, we have sorely needed more sequence, from an animal like the Rhesus monkey.


I'll finish up with an example from my own work in yeast. Certain proteins, which are master regulators of cell division, modify target proteins at the sequence 'TP..any letter..R or K'. (Now we're talking about protein sequence, so we don't just have A's, T's, G's, and C's.) To understand how these master regulators carry out their role, we would like to know exactly which proteins are their targets. How do we find those targets? Easy - just look for any protein that has 'TP..any letter..R or K' in it, and you have a candidate protein that you can test in the lab!

Well, it turns out it's not so easy - many proteins have this 'TP..any letter..R or K' just by chance - too many to test in the lab. So we want to choose the most likely targets - those whose sequence has been conserved throughout evolution. You can line up the sequences from different species, and easily see the 'TP..any letter..R or K' which has been conserved over 100 million years of evolution:



The sequence on the top line is from baker's yeast, and the sequence on the bottom is from a yeast that shared an ancestor with baker's yeast 100 million years back.

Comparative genomics really works. It has helped us learn a tremendous amount about flies, worms, and yeast. With the macaque genome, we'll hopefully have the same success learning about our own genome.

Thursday, November 30, 2006

Sequencing technology and the Neanderthal Genome

You've probably read about the two recent papers in Science and Nature reporting the sequencing of portions of the Neanderthal Genome. (Subscription required for full text of the Nature and Science papers. Check out Google for the many news stories on this.) This is exciting work, but I'm not really going to comment about the signficance of the results - I think it's worth understanding how new sequencing technology enabled researchers to sequence 1 million bases of 38,000 year-old DNA.

Each group used a different sequencing technology, and as a result, their coverage of the genome differed widely: the Nature group got about 1 million base pairs of sequence, while the Science group got about 65,000 base pairs. (Recall that the human genome contains about 3 billion base pairs, and the Neanderthal genome was undoubtedly similar.) The Neanderthal genome is a challenge because, obviously, any DNA remaining in the 30,000-40,000 year old bones we have is highly fragmented, and the amount of contaminating DNA from microbes (not to mention scientists) is significant. To eventually cover the entire genome, we need a method that can generate lots and lots of sequence without being prohibitively expensive.

The Science group used a more traditional method, which works well for most large-scale genome sequencing efforts, but is not really well-suited for getting huge chunks of Neanderthal genome. As a result, this group obtained only 65,000 base pairs of DNA sequence (which is still a significant accomplishment.) The big problem with this method is that the fragments of DNA isolated from Neanderthal bones have to be cloned before they can be sequenced. (In layman's terms - the DNA fragments have to be placed inside circular pieces of DNA called plasmids, which can be then grown in large quantities inside bactieria.) Many fragments of Neanderthal DNA fail to be cloned at this point, meaning that you lose much of the sample that was painstakingly isolated from the ancient bones.


The Nature group used something called pyrosequencing, which is done on machines called 454 sequencers. Crucially, this technique does not require a cloning step, which means much more of the isolated sample gets sequenced. Pyrosequencing also produces lots and lots of sequencing data very quickly. (One major downside is that each sequence is much shorter than what you get using traditional Sanger Sequencing, by a factor of ten at least. But in this case, the Neanderthal DNA fragments are so short this doesn't matter.)

You can read a really nice explanation of how pyrosequencing works at 454's web site. (For more technical coverage, look here.) Without this technology, a Neanderthal genome project would not be feasible. With this technology, we can now consider all sorts of sequencing projects that would not have been financially or technically feasible before - not just Neanderthal sequencing, but also large scale studies of gene varation in natural populations, including humans. Such large-scale sequencing could help up close in on the genes involved in complex diseases.

I said I was going to talk about sequencing, but I can't resist making a plug for completing the Neanderthal genome. It's interesting to learn about the changes in the genome that took place during evolution, but it's also extremely useful to have a more closely related genome as we try to find and understand the functional portions of the human genome. Having multiple genomes of close species has helped enormously in flies, worms, and yeast (for examples, check out this, this, and this). As is usual in almost any genome-level study of human biology, you can't get far without using an understanding of evolution.

Thursday, October 26, 2006

Comparing Genomes on a Chip

Last week at our lab meeting I had a chance to hear a presentation by Doug Berg, a microbiologist here at Washington University. Berg's work is a great combination of new technology, genomics and evolution, and it happens to also have potential medical relevance. He's studying the evolution of drug resistance in Helicobacter pylori, a ususally benign bacterium that is responsible for stomach ulcers. (Recall that the Nobel Prize in medicine was awarded last year to Barry Marshall and Robin Warren for their discovery of the link between H. pylori and ulcers.)

Berg is basically evolving highly drug resistant bacteria in the lab and using a new genome comparison technology to identify the genes that are changed as the bacterial strains become more resistant. The drug used in these experiments is metronidazole - a substance that itself is not harmful, but inside a bacterial cell it is metabolized into a toxin that causes significant DNA damage.

To create these drug-resistant strains, bacteria are spread on an agar plate - a peteri dish filled with a Jello-like substance that contains nutrients and metronidazole. Most bacteria are killed by the drug, but some individual bacteria survive, if they harbor random mutations that just happen to confer drug resistance. These surviving bacteria continue to divide, and after a few days a colony - a blob of bacteria all descended from the original surviving bacterium - has formed on the plate. You can pick off this colony with a toothpick and save it; you now have a drug resistant strain of bacteria. This process can be repeated - grow up the drug resistant strain, smear it on an agar plate with a higher concentration of the drug, and watch for the next round of colonies to grow from the survivors.

After doing many experiments like this, the Berg lab gets a series of H. pylori strains, each with varying drug resistance. The obvious question then is, how do the genomes of these strains differ? What specific (but randomly occuring) mutations had to take place in order for this level of drug resistance to evolve? Sequencing the genomes of each of these various drug-resistant strains would be the obvious way to find these differences, but doing that kind of sequencing is still prohibitively expensive and computationally intentive. But the Berg lab is using a new technique that rapidly compares genomes on a chip. (The link leads to an abstract of their paper; the full text is subscription only but you can check out more about the technique in a "webinar" found here, at the bottom of the page.). They use microarrays (DNA chips) that cover the entire genome (called a 'tiling array'). By hybridizing DNA from both the nomral and drug resistant strains to the microarray (check out my earlier summary of how a microarray works), they can identify those spots on the array (and thus in the genome) where the two strains differ.

Using this technique, the Berg lab has identified key genes involved in H. pylori resistance to metronidozole. There seem to be some genes that are always changed in these drug resistant strains, and some that can be different. In other words, there seem to be multiple evolutionary paths to drug resistance, but those paths often cross.

This techique of comparing genomes on a chip has a lot of potential, and within a few years, something like this may start showing up in common medical care and hospital labs, replacing the more primitive techniques that are currently used for classifying tumors or drug-resistant pathogens.

Thursday, December 22, 2005

The Dog Genome - part 1 Why sequence genomes?

I was excited to see the paper on the dog genome in the Dec. 8 issue of Nature. These genome papers offer so many interesting insights about many different aspects of biology - in fact, genome sequencing touches on so many different fields that it's worth reviewing why we sequence genomes. Genome sequencing is a resource-intensive effort, so it's important to understand why this effort is justified.

Molecular Biology: Molecular biologists have long sought to understand the structure and function of the molecular parts of the cell. Like physiologists who study whole organisms, molecular biologists want to know what everything in the cell does. Ideally, we would like to determine the function(s) of every protein made in an organism, the 3-D structure of each of these proteins, the conditions under which these proteins are expressed, how they interact with each other and the non-protein parts of the cell, which portions of our DNA contain regulatory sequences that control gene expression and how those sequences work, etc. etc. In other words, we want to a complete mechanistic picture of the cell.

To even come close to this goal, we must know the DNA sequence of the genome, because every protein and RNA component of the cell is coded by our DNA. By having a genome sequence, we basically have a complete parts list for the cell, even if we don't completely know how to read that list yet. With this parts list, one can make a complete collection of protein-coding genes in an experimentally useful form, and then study those genes systematically. (In a shameless act of self-promotion, I recommend you check out this relevant abstract recently published by our group.) This type of approach has been extensively used in yeast, but can also work for human genes. Another application is the creation of DNA chips, or microarrays, which have been tremendously useful in recent years. Without genome sequences, we could not build these collections and perform such genome-wide experiments.

An advantage of sequencing multiple mammalian genomes (human, chimp, mouse, rat, and now dog), is that we can compare them. This is useful for evolutionary studies (which I'll get to in the next post), but it is also crucial for those purely interested in mechanistic molecular biology. Identifying functionally important portions of a single genome is extremely difficult. Even protein-coding genes are hard to identify. Protein coding genes start with the DNA sequence ATG and end with TAG, TAA, or TGA, with a stretch of DNA in between coding for the amino acids of the protein, like this gene for the human cannabinoid receptor-1, which is the receptor acted on by the major active component of marijuana:

ATGAAGTCGATCCTAGATGGCCTTGCAGATAC
CACCTTCCGCACCATCACCACTGACCTCCTGTACGTGGG
CTCAAATGACATTCAGTACGAAGACATCAAAGGTGACAT
GGCATCCAAATTAGGGTACTTCCCACAGAAATTCCCTTT
AACTTCCTTTAGGGGAAGTCCCTTCCAAGAGAAGATGAC
TGCGGGAGACAACCCCCAGCTAGTCCCAGCAGACCAGGT
GAACATTACAGAATTTTACAACAAGTCTCTCTCGTCCTTC
AAGGAGAATGAGGAGAACATCCAGTGTGGGGAGAACTTC
ATGGACATAGAGTGTTTCATGGTCCTGAACCCCAGCCAG
CAGCTGGCCATTGCAGTCCTGTCCCTCACGCTGGGCACC
TTCACGGTCCTGGAGAACCTCCTGGTGCTGTGCGTCATC
CTCCACTCCCGCAGCCTCCGCTGCAGGCCTTCCTACCAC
TTCATCGGCAGCCTGGCGGTGGCAGACCTCCTGGGGAGT
GTCATTTTTGTCTACAGCTTCATTGACTTCCACGTGTTCC
ACCGCAAAGATAGCCGCAACGTGTTTCTGTTCAAACTGG
GTGGGGTCACGGCCTCCTTCACTGCCTCCGTGGGCAGCC
TGTTCCTCACAGCCATCGACAGGTACATATCCATTCACAG
GCCCCTGGCCTATAAGAGGATTGTCACCAGGCCCAAGGC
CGTGGTGGCGTTTTGCCTGATGTGGACCATAGCCATTGTG
ATCGCCGTGCTGCCTCTCCTGGGCTGGAACTGCGAGAAAC
TGCAATCTGTTTGCTCAGACATTTTCCCACACATTGATGAA
ACCTACCTGATGTTCTGGATCGGGGTCACCAGCGTACTGCT
TCTGTTCATCGTGTATGCGTACATGTATATTCTCTGGAAGG
CTCACAGCCACGCCGTCCGCATGATTCAGCGTGGCACCCAG
AAGAGCATCATCATCCACACGTCTGAGGATGGGAAGGTACA
GGTGACCCGGCCAGACCAAGCCCGCATGGACATTAGGTTAG
CCAAGACCCTGGTCCTGATCCTGGTGGTGTTGATCATCTGCT
GGGGCCCTCTGCTTGCAATCATGGTGTATGATGTCTTTGGGA
AGATGAACAAGCTCATTAAGACGGTGTTTGCATTCTGCAGTA
TGCTCTGCCTGCTGAACTCCACCGTGAACCCCATCATCTATG
CTCTGAGGAGTAAGGACCTGCGACACGCTTTCCGGAGCATGT
TTCCCTCTTGTGAAGGCACTGCGCAGCCTCTGGATAACAGCA
TGGGGGACTCGGACTGCCTGCACAAACACGCAAACAATGCAG
CCAGTGTTCACAGGGCCGCAGAAAGCTGCATCAAGAGCACGG
TCAAGATTGCCAAGGTAACCATGTCTGTGTCCACAGACACGT
CTGCCGAGGCTCTGTGA


The hard part is that not all DNA sequences that fit those criteria are actually protein coding genes - some DNA sequences look like protein coding genes, but they really aren't.

Furthermore, functionally important DNA sequences that do not code for proteins don't start with ATG and end with TAG, TAA or TGA. We can't identify these sites by just looking for certain features in a single genome. This is where genome sequencing is useful - to identify functionally important portions of our genome, whether they code for protein or not, we can compare genomes of related organisms at various evolutionary distances from ours. Because of evolution, genomes change; those parts that are not functionally important can usually change without adverse consequences for the fitness of the organism, while the parts that are functionally important will generally be constrained. So you can compare genomes of various organisms and look for those parts that haven't changed very much; this is a major clue that these parts are authentic functional sequences. If a DNA sequence starts with ATG and ends with TGA, but is poorly conserved among different species, this may not be a true protein coding gene. (On the other hand, it could be a rapidly evolving gene involved in a function like reproduction or the immune system; there are way to test for this.) If a non-coding DNA sequence close to a protein-coding gene is very similar among different species, this sequence could be involved in regulating the nearby protein-coding gene. (Keep in mind, I'm really simplifying things, but this is the basic idea behind comparative genomics.) This is illustrated in the following schematic:



Potential protein-coding genes start with ATG and and with TGA; the blue gene is conserved between human and mouse, while the green gene is not. The blue gene is probably an authentic protein-coding gene, while the green one may not be. The red sequence is not a protein coding sequence, but it is conserved between mouse and human, thus it may be functionally important.

One important problem is choosing the right organisms. Let's say that we're comparing the chimp genome with the human genome and we find a region of DNA that is very similar in the two genomes. It's possible that this region is similar because it is functionally important, or it could be that this region simply hasn't changed much yet because humans and chimps diverged so recently (on an evolutionary scale - 5-6 million years ago). To resolve this issue, we look at the genomes of other organisms, such the mouse or dog. The human and dog genomes diverged much farther back in time, so DNA sequences that are conserved among these two genomes are very likely to be functionally relevant. (On the other hand, the human and dog lineages have diverged enough that some functionally important sequences may not be that similar, which is why we look at an intermediate genome, like mouse or rat.)

This kind of comparison has been very useful in yeast (check out this paper and this one), helping researchers to better define protein-coding genes and non-coding regulatory elements. With this knowledge, we can focus our experimental efforts on systematically characterizing these genomic elements.

In a nutshell, this is one rationale for sequencing genomes. In the next installment, I'll talk about how genomes help us understand evolution, and why the dog genome in particular is useful for studying mammalian evolution.